sábado, 18 de octubre de 2025

Editorial e1 Women's health for all The Lancet Obstetrics, Gynaecology, & Women's Health + +... +...

Adjuvant prophylactic human papillomavirus vaccination for prevention of recurrent high-grade cervical intraepithelial neoplasia lesions in women undergoing lesion surgical treatment (VACCIN): a multicentre, phase 4 randomised placebo-controlled trial in the Netherlands https://www.thelancet.com/journals/lanogw/article/PIIS3050-5038(25)00007-X/abstract?utm_campaign=infocusalerts-obgyn&utm_medium=email&dgcid=hubspot_email_infocusalerts-obgyn_feature&_hsenc=p2ANqtz-9VHph37vbJkGIHYkJxExZnPxElYQUaR5qyAjurHc5D9HX8sAbvmoQv7bmC-ZSS0W5e6wyLPYRryGk_50fjtU6RJXF9MQ&_hsmi=385677682&utm_content=385069361&utm_source=hs_email Editorial e1 Women's health for all The Lancet Obstetrics, Gynaecology, & Women's Health https://www.thelancet.com/journals/lanogw/issue/vol1no1/PIIS3050-5038(25)X0002-9 Obstetrics, Gynaecology, & Women’s Health https://www.thelancet.com/collections/obstetrics-gynaecology-womens-health?dgcid=hubspot_email_infocusalerts-obgyn_feature&parent=001603&startPage=&ContentItemType=fla&utm_campaign=infocusalerts-obgyn&utm_medium=email&_hsenc=p2ANqtz--qvzMiyhDY6AZPE-KBewirAR8ADxoZOPd4SFS_6o7lI933_mw86b9gPcxWln7dz5Z-nL2aETZm8rwhS8BM3XrebPbE7A&_hsmi=385677682&utm_content=385069361&utm_source=hs_email

No hay comentarios:

Publicar un comentario